Jean-Pierre J Issa Selected Research

Pain (Aches)

1/2018

Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root Ganglion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Pierre J Issa Research Topics

Disease

80	Neoplasms (Cancer) 01/2024 - 01/2002
16	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2003
15	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2019 - 04/2006
10	Colonic Neoplasms (Colon Cancer) 01/2024 - 01/2002
9	Leukemia 01/2017 - 06/2002
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 04/2006
8	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2003
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 07/2002
6	Myeloid Leukemia (Leukemia, Myelocytic) 05/2017 - 05/2006
6	Carcinogenesis 11/2010 - 01/2004
4	Melanoma (Melanoma, Malignant) 12/2015 - 08/2006
4	Adenoma (Adenomas) 02/2014 - 04/2005
4	Chromosomal Instability (Chromosome Stability) 04/2009 - 11/2003
3	Carcinoma (Carcinomatosis) 01/2023 - 05/2003
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 07/2015 - 01/2007
3	Stomach Neoplasms (Stomach Cancer) 10/2013 - 12/2003
3	Prostatic Neoplasms (Prostate Cancer) 06/2008 - 07/2007
3	Microsatellite Instability 05/2008 - 05/2003
3	Philadelphia Chromosome 11/2007 - 07/2002
2	Neutropenia 12/2023 - 08/2006
2	Atherosclerosis 01/2023 - 01/2007
2	Inflammation (Inflammations) 11/2022 - 09/2012
2	Triple Negative Breast Neoplasms 06/2021 - 01/2018
2	Adenocarcinoma of Lung 01/2021 - 12/2009
2	Adenocarcinoma 01/2021 - 12/2009
2	Infections 02/2014 - 08/2006
2	Glioma (Gliomas) 07/2013 - 04/2011
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2011 - 07/2007
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2008 - 04/2005
2	Acute Promyelocytic Leukemia 12/2007 - 10/2006
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 11/2007 - 11/2005
2	Hematologic Neoplasms (Hematological Malignancy) 02/2007 - 03/2004
1	Febrile Neutropenia 12/2023
1	Pneumonia (Pneumonitis) 12/2023
1	COVID-19 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Opioid-Related Disorders (Opiate Addiction) 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Cross Infection (Nosocomial Infection) 11/2022
1	Adenocarcinoma in Situ 01/2021
1	Hyperplasia 01/2021

Drug/Important Bio-Agent (IBA)

30	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 01/2002
25	Decitabine FDA Link 01/2024 - 03/2004
15	hydrogen sulfite (bisulfite)IBA 01/2021 - 05/2002
13	ChromatinIBA 01/2024 - 08/2003
12	Histones (Histone)IBA 07/2022 - 01/2002
11	MethyltransferasesIBA 01/2019 - 05/2003
8	guadecitabineIBA 12/2023 - 09/2015
8	Azacitidine (5 Azacytidine)FDA Link 12/2023 - 05/2006
7	Calcibiotic Root Canal SealerIBA 02/2014 - 01/2004
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2008
6	Protein Isoforms (Isoforms)IBA 08/2017 - 01/2004
6	Histone Deacetylase InhibitorsIBA 01/2017 - 08/2003
6	Estrogen ReceptorsIBA 01/2017 - 05/2002
6	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 07/2002
5	Proteins (Proteins, Gene)FDA Link 04/2011 - 10/2006
5	CytosineIBA 05/2008 - 01/2002
3	EnzymesIBA 01/2023 - 01/2010
3	Hormones (Hormone)IBA 01/2018 - 01/2007
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2017 - 12/2007
3	retinoic acid receptor betaIBA 06/2009 - 05/2003
3	Lysine (L-Lysine)FDA Link 06/2008 - 08/2003
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2007 - 04/2004
3	A-Form DNA (A-DNA)IBA 06/2005 - 12/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2023 - 07/2007
2	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2018
2	Transcription Factors (Transcription Factor)IBA 07/2015 - 10/2005
2	PlatinumIBA 01/2015 - 01/2015
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2013 - 06/2009
2	Retroelements (Retrotransposon)IBA 10/2012 - 10/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2012 - 06/2011
2	Cadherins (E-Cadherin)IBA 01/2010 - 06/2004
2	GuanineIBA 05/2008 - 02/2003
2	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 12/2007 - 10/2006
2	Messenger RNA (mRNA)IBA 11/2007 - 05/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2007 - 08/2006
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2003 - 04/2002
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 05/2003 - 05/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2003 - 05/2002
2	bcr-abl Fusion ProteinsIBA 07/2002 - 07/2002
1	Cyclin-Dependent Kinase 9IBA 01/2024
1	atezolizumabIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2023
1	CreatinineIBA 01/2023
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2023
1	HomocysteineIBA 01/2023
1	LigandsIBA 01/2023
1	Methadone (Dolophine)FDA LinkGeneric 01/2023
1	Naloxone (Narcan)FDA LinkGeneric 01/2023
1	Lipoprotein(a)IBA 01/2023
1	16S Ribosomal RNAIBA 11/2022
1	Adenosine (Adenocard)FDA LinkGeneric 07/2022
1	ToyocamycinIBA 07/2022
1	Cell-Free Nucleic AcidsIBA 01/2021

Therapy/Procedure

29	Therapeutics 01/2023 - 12/2003
6	Drug Therapy (Chemotherapy) 07/2022 - 10/2007
2	Aftercare (After-Treatment) 01/2023 - 12/2003
1	Induction Chemotherapy 12/2023